中东和非洲细胞和基因治疗解冻设备市场，按方式（台式和便携式）、样品（细胞疗法和基因疗法）、类型（手动解冻系统和自动解冻系统）、应用（上游处理和下游处理）、最终用户（血库和输血中心、医院和诊断实验室、研究实验室和学术机构、生物技术和制药行业、脐带血和干细胞库、基因库和其他）、分销渠道（直接招标、第三方分销商和其他）、国家（南非、沙特阿拉伯、阿联酋、埃及、以色列和中东及非洲其他地区）行业趋势和预测到 2028 年。
市场分析与洞察：中东和非洲细胞和基因治疗解冻设备市场
细胞和基因治疗解冻设备市场预计将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析，在 2021 年至 2028 年的预测期内，该市场以 10.8% 的复合年增长率增长，预计到 2028 年将达到 5883 万美元。慢性病患病率的上升需要先进的细胞和基因治疗解冻设备解决方案和服务，从而成为细胞和基因治疗解冻设备市场增长的驱动力。
由于技术的进步，细胞和基因治疗解冻设备变得容易，因为许多主要市场参与者正在开发和推出新的解决方案来扩大其市场。此外，发达国家和发展中国家医疗保健支出的增加推动了细胞和基因治疗解冻设备市场的增长。由于慢性病发病率的增加和技术进步的提高，细胞和基因治疗解冻设备市场正在增长。
慢性病患病率的上升推动了细胞和基因治疗解冻设备市场的发展。细胞和基因治疗工程相关成本的上升降低了对细胞和基因治疗解冻设备的需求，从而限制了细胞和基因治疗解冻设备市场的增长。新技术进步的激增为细胞和基因治疗解冻设备市场带来了机遇。然而，中低收入国家缺乏可及性，这对细胞和基因治疗解冻设备市场的增长构成了挑战。
细胞和基因治疗解冻设备市场报告提供了市场份额、新发展和产品线分析、国内和本地市场参与者的影响的详细信息，分析了新兴收入领域、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和细胞和基因治疗解冻设备市场情景，请联系 Data Bridge Market Research 获取分析师简报，我们的团队将帮助您创建收入影响解决方案以实现您的预期目标。
细胞和基因治疗解冻设备市场范围和市场规模
细胞和基因治疗解冻设备市场根据模式、样本、类型、应用、最终用户、分销渠道进行细分。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。
- 根据样本，细胞和基因治疗解冻设备市场细分为细胞治疗和基因治疗。由于癌症患病率和发病率上升，预计 2021 年细胞治疗领域将主导细胞和基因治疗解冻设备市场。
- 根据类型，细胞和基因治疗解冻设备市场分为手动解冻系统和自动解冻系统。2021 年，自动解冻系统预计将主导细胞和基因治疗解冻设备市场，因为它提高了可重复性并最大限度地减少了人为错误。
- 根据应用，细胞和基因治疗解冻设备市场分为上游加工和下游加工。由于解冻系统的技术进步，预计 2021 年上游加工领域将主导细胞和基因治疗解冻设备市场。
- 根据最终用户，细胞和基因治疗解冻设备市场细分为血库和输血中心、医院和诊断实验室、研究实验室和学术机构、生物技术和制药行业、脐带血和干细胞库、基因库等。2021 年，由于中低收入国家血库和先进医疗保健提供商数量的增加，血库部门预计将在细胞和基因治疗解冻设备市场中占据主导地位。
- 根据分销渠道，细胞和基因治疗解冻设备市场分为直接招标、第三方分销商和其他。2021 年，直接招标部分预计将主导细胞和基因治疗解冻设备市场，因为大多数医疗保健提供商都是通过直接招标采购细胞和基因治疗解冻设备的。
细胞和基因治疗解冻设备市场国家级分析
细胞和基因治疗解冻设备市场根据方式、样本、类型、应用、最终用户、分销渠道进行细分。
细胞和基因治疗解冻设备市场报告涉及的国家包括南非、沙特阿拉伯、阿联酋、以色列、埃及以及中东和非洲的其他国家。
随着慢性病患病率的不断上升，南非预计将在市场中占据主导地位。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀少的竞争而面临的挑战、销售渠道的影响。
主要市场参与者不断增加的战略活动提高了对细胞和基因治疗解冻设备的认识，正在推动细胞和基因治疗解冻设备市场的市场增长
细胞和基因治疗解冻设备市场还为您提供每个国家特定市场增长的详细市场分析。此外，它还提供有关市场参与者战略及其地理分布的详细信息。数据适用于 2010 年至 2019 年的历史时期。
竞争格局和细胞及基因治疗解冻设备市场份额分析
细胞和基因治疗解冻设备市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用主导地位、技术生命线曲线。以上提供的数据点仅与公司对细胞和基因治疗解冻设备市场的关注有关。
从事细胞和基因治疗解冻设备业务的主要公司包括 Pluristem Therapeutics Inc.、Genesis BPS、Eppendorf AG、Cytiva（丹纳赫集团的子公司）、Glenmark Pharmaceutical Inc.、USA（Glenmark 的子公司）、EDGE pharma、Cook、SARSTEDT AG & Co. KG、Barkey、Boekel Scientific、LABCOLD、Sartorious AG 和 Helmer Scientific Inc. 以及其他国内公司。DBMR 分析师了解竞争优势，并为每个竞争对手分别提供竞争分析。
全球各地的公司也签订了许多合同和协议，这也加速了细胞和基因治疗解冻设备市场的发展。
例如，
- 2020 年 11 月，Eppendorg AG 在印度推出了用于细胞解冻的 SmartBlock。Smart Block 细胞解冻是下游处理的基础。对于科学家来说，在每个细胞处理实验室中进一步使用都非常简单方便。
市场参与者的合作、产品发布、业务扩展、奖励和认可、合资企业等策略正在增强公司在细胞和基因治疗解冻设备市场的影响力，这也为组织的利润增长带来了好处。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET APPLICATION COVERAGE GRID
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 USAGE OF THAWING EQUIPMENT IN UPSTREAM AND DOWNSTREAM PROCESSES
5.1 UPSTREAM PROCESS
5.2 DOWNSTREAM PROCESS
6 CELL AND GENE THERAPY WORKFLOW USING THAWING EQUIPMENT
7 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: REGULATIONS
7.1 CANADA
7.2 THE U.S.
7.3 EUROPE
7.4 GENE THERAPY LEGISLATION IN AUSTRIA
7.5 GENE THERAPY LEGISLATION IN BULGARIA
7.6 JAPAN
7.7 ITALY
7.8 MALAYSIA
8 REGIONAL SUMMARY
9 MARKET OVERVIEW
9.1 DRIVERS
9.1.1 INCREASE IN CASES OF GENETIC DISEASES SUCH AS CYSTIC FIBROSIS AND SICKLE CELL ANEMIA
9.1.2 RISE IN INVESTMENT IN R&D FOR DEVELOPMENT OF CELL AND GENE THERAPIES
9.1.3 GOVERNMENT INITIATIVES FOR INITIATION OF CELL AND GENE THERAPY FIELD
9.1.4 INCREASED IMPLEMENTATION OF ADENO-ASSOCIATED VIRUS
9.1.5 TECHNOLOGICAL ADVANCEMENTS IN THE THAWING SYSTEMS
9.2 RESTRAINTS
9.2.1 RISE IN COST ASSOCIATED WITH CELL AND GENE THERAPY ENGINEERING
9.2.2 RISE OF UNWANTED MUTAGENS
9.2.3 TECHNICAL HINDRANCE FACED IN USING THAWING INSTRUMENTS
9.2.4 STRICT REGULATORY FRAMEWORK
9.3 OPPORTUNITIES
9.3.1 INCREASING PREVALENCE OF CANCER
9.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS
9.3.3 RISE IN EXPENDITURE IN HEALTHCARE SECTOR
9.4 CHALLENGES
9.4.1 LONG APPROVAL TIME FOR IMMUNOTHERAPIES
9.4.2 LACK OF ACCESSIBILITY
10 IMPACT OF COVID-19 ON MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET
10.1 IMPACT ON PRICE
10.2 IMPACT ON DEMAND
10.3 IMPACT ON SUPPLY CHAIN
10.4 STRATEGIC DECISION FOR MANUFACTURERS
10.5 CONCLUSION
11 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY
11.1 OVERVIEW
11.2 BENCH TOP
11.3 PORTABLE
12 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE
12.1 OVERVIEW
12.2 CELL THERAPIES
12.2.1 CAR T CELLS
12.2.2 NK CELLS
12.2.3 MSCS
12.2.4 TILS
12.2.5 OTHERS
12.3 GENE THERAPIES
12.3.1 ADENOVIRUS
12.3.2 ADENO-ASSOCIATED VIRUSES
12.3.3 LENTIVIRUSES
12.3.4 ONCOLYTIC VIRUSES
12.3.5 OTHERS
13 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE
13.1 OVERVIEW
13.2 AUTOMATIC THAWING SYSTEM
13.3 MANUAL THAWING SYSTEM
14 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION
14.1 OVERVIEW
14.2 UPSTREAM PROCESSING
14.2.1 AUTOMATIC THAWING SYSTEM
14.2.2 MANUAL THAWING SYSTEM
14.3 DOWNSTREAM PROCESSING
14.3.1 AUTOMATIC THAWING SYSTEM
14.3.2 MANUAL THAWING SYSTEM
15 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER
15.1 OVERVIEW
15.2 HOSPITALS AND DIAGNOSTIC LABORATORIES
15.3 BLOOD BANKS AND TRANSFUSION CENTERS
15.4 RESEARCH LABORATORIES AND ACADEMIC INSTITUTES
15.5 BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRY
15.6 CORD BLOOD AND STEM CELL BANKS
15.7 GENE BANKS
15.8 OTHERS
16 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL
16.1 OVERVIEW
16.2 DIRECT TENDER
16.3 THIRD PARTY DISTRIBUTORS
16.4 OTHERS
17 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION
17.1 MIDDLE EAST AND AFRICA
17.1.1 SOUTH AFRICA
17.1.2 SAUDI ARABIA
17.1.3 U.A.E.
17.1.4 EGYPT
17.1.5 ISRAEL
17.1.6 REST OF MIDDLE EAST AFRICA
18 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, COMPANY LANDSCAPE
18.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
19 SWOT ANALYSIS
20 COMPANY PROFILE
20.1 MERCK KGAA
20.1.1 COMPANY SNAPSHOT
20.1.2 REVENUE ANALYSIS
20.1.3 PRODUCT PORTFOLIO
20.1.4 RECENT DEVELOPMENTS
20.2 EPPENDORF AG
20.2.1 COMPANY SNAPSHOT
20.2.2 REVENUE ANALYSIS
20.2.3 PRODUCT PORTFOLIO
20.2.4 RECENT DEVELOPMENTS
20.3 SARTORIUS AG
20.3.1 COMPANY SNAPSHOT
20.3.2 REVENUE ANALYSIS
20.3.3 PRODUCT PORTFOLIO
20.3.4 RECENT DEVELOPMENT
20.4 CYTIVA (A SUBSIDIARY OF DANAHER CORPORATION)
20.4.1 COMPANY SNAPSHOT
20.4.2 REVENUE ANALYSIS
20.4.3 PRODUCT PORTFOLIO
20.4.4 .RECENT DEVELOPMENTS
20.5 BARKEY
20.5.1 COMPANY SNAPSHOT
20.5.2 PRODUCT PORTFOLIO
20.5.3 RECENT DEVELOPMENTS
20.6 BOEKEL SCIENTIFIC
20.6.1 COMPANY SNAPSHOT
20.6.2 PRODUCT PORTFOLIO
20.6.3 RECENT DEVELOPMENT
20.7 BIOLINE INDIA
20.7.1 COMPANY SNAPSHOT
20.7.2 PRODUCT PORTFOLIO
20.7.3 RECENT DEVELOPMENTS
20.8 COOK
20.8.1 COMPANY SNAPSHOT
20.8.2 PRODUCT PORTFOLIO
20.8.3 RECENT DEVELOPMENT
20.9 GENESIS BPS
20.9.1 COMPANY SNAPSHOT
20.9.2 PRODUCT PORTFOLIO
20.9.3 RECENT DEVELOPMENTS
20.1 HELMER SCIENTIFIC INC.
20.10.1 COMPANY SNAPSHOT
20.10.2 PRODUCT PORTFOLIO
20.10.3 RECENT DEVELOPMENTS
20.11 LABCOLD
20.11.1 COMPANY SNAPSHOT
20.11.2 PRODUCT PORTFOLIO
20.11.3 RECENT DEVELOPMENTS
20.12 PLEURISTEM THERAPEUTICS INC.
20.12.1 COMPANY SNAPSHOT
20.12.2 REVENUE ANALYSIS
20.12.3 PRODUCT PORTFOLIO
20.12.4 RECENT DEVELOPMENTS
20.13 SARSTEDT AG & CO. KG
20.13.1 COMPANY SNAPSHOT
20.13.2 PRODUCT PORTFOLIO
20.13.3 RECENT DEVELOPMENTS
21 QUESTIONNAIRE
22 RELATED REPORTS
表格列表
TABLE 1 TOTAL HEALTH SPENDING BY THE U.S. (2015-2016)
TABLE 2 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 3 MIDDLE EAST AND AFRICA BENCH TOP IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 4 MIDDLE EAST AND AFRICA PORTABLE IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 5 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 6 MIDDLE EAST AND AFRICA CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 MIDDLE EAST AND AFRICA CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 8 MIDDLE EAST AND AFRICA GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 MIDDLE EAST AND AFRICA GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 10 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 11 MIDDLE EAST AND AFRICA AUTOMATIC THAWING SYSTEM IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 MIDDLE EAST AND AFRICA MANUAL THAWING SYSTEM IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 14 MIDDLE EAST AND AFRICA UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 MIDDLE EAST AND AFRICA UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 16 MIDDLE EAST AND AFRICA DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 MIDDLE EAST AND AFRICA DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 18 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 19 MIDDLE EAST AND AFRICA HOSPITALS AND DIAGNOSTIC LABORATORIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 MIDDLE EAST AND AFRICA BLOOD BANKS AND TRANSFUSION CENTERS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 MIDDLE EAST AND AFRICA RESEARCH LABORATORIES AND ACADEMIC INSTITUTES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 MIDDLE EAST AND AFRICA BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRY IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 MIDDLE EAST AND AFRICA CORD BLOOD AND STEM CELL BANKS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 MIDDLE EAST AND AFRICA GENE BANKS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 25 MIDDLE EAST AND AFRICA OTHERS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 27 MIDDLE EAST AND AFRICA DIRECT TENDER IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 MIDDLE EAST AND AFRICA THIRD PARTY DISTRIBUTORS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 MIDDLE EAST AND AFRICA OTHERS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 33 MIDDLE EAST & AFRICA CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 34 MIDDLE EAST & AFRICA GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 35 MIDDLE EAST & AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 36 MIDDLE EAST & AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 37 MIDDLE EAST & AFRICA UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 38 MIDDLE EAST & AFRICA DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 39 MIDDLE EAST & AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 40 MIDDLE EAST & AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 41 SOUTH AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 42 SOUTH AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 43 SOUTH AFRICA CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 44 SOUTH AFRICA GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 45 SOUTH AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 46 SOUTH AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 47 SOUTH AFRICA UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 48 SOUTH AFRICA DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 49 SOUTH AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 50 SOUTH AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 51 SAUDI ARABIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 52 SAUDI ARABIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 53 SAUDI ARABIA CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 54 SAUDI ARABIA GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 55 SAUDI ARABIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 56 SAUDI ARABIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 57 SAUDI ARABIA UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 58 SAUDI ARABIA DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 59 SAUDI ARABIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 60 SAUDI ARABIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 61 U.A.E. CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 62 U.A.E. CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 63 U.A.E. CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 64 U.A.E. GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 65 U.A.E. CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 66 U.A.E. CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 67 U.A.E. UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 68 U.A.E. DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 69 U.A.E. CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 70 U.A.E. CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 71 EGYPT CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 72 EGYPT CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 73 EGYPT CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 74 EGYPT GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 75 EGYPT CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 76 EGYPT CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 77 EGYPT UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 78 EGYPT DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 79 EGYPT CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 80 EGYPT CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 81 ISRAEL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 82 ISRAEL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 83 ISRAEL CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 84 ISRAEL GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 85 ISRAEL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 86 ISRAEL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 87 ISRAEL UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 88 ISRAEL DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 89 ISRAEL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 90 ISRAEL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 91 REST OF MIDDLE EAST AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
图片列表
FIGURE 1 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: MULTIVARIATE MODELLING
FIGURE 7 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: DBMR MARKET POSITION GRID
FIGURE 9 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 11 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: SEGMENTATION
FIGURE 12 NORTH AMERICA IS EXPECTED TO DOMINATE THE MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 13 INCREASE IN CASES OF GENETIC DISEASES SUCH AS CARDIAC AILMENTS, CYSTIC FIBROSIS AND AIDS IS EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 14 TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET IN 2021 & 2028
FIGURE 15 PESTEL ANALYSIS
FIGURE 16 PORTERS FIVE FORCES MODEL
FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET
FIGURE 18 INCIDENCE OF CYSTIC FIBROSIS OBSERVED IN THE COUNTRIES
FIGURE 19 PREVALENCE OF SICKLE CELL ANEMIA IN AFRICA AND EUROPE
FIGURE 20 NEW CANCER CASES WORLDWIDE, (2018) (IN MILLION)
FIGURE 21 MIDDLE EAST AND AFRICA CANCER INCIDENCE (2018)
FIGURE 22 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY MODALITY, 2020
FIGURE 23 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY MODALITY, 2021-2028 (USD MILLION)
FIGURE 24 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY MODALITY, CAGR (2021-2028)
FIGURE 25 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY MODALITY, LIFELINE CURVE
FIGURE 26 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY SAMPLE, 2020
FIGURE 27 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY SAMPLE, 2021-2028 (USD MILLION)
FIGURE 28 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY SAMPLE, CAGR (2021-2028)
FIGURE 29 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY SAMPLE, LIFELINE CURVE
FIGURE 30 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY TYPE, 2020
FIGURE 31 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY TYPE, 2021-2028 (USD MILLION)
FIGURE 32 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY TYPE, CAGR (2021-2028)
FIGURE 33 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY TYPE, LIFELINE CURVE
FIGURE 34 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY APPLICATION, 2020
FIGURE 35 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY APPLICATION, 2021-2028 (USD MILLION)
FIGURE 36 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 37 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 38 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY END USER, 2020
FIGURE 39 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY END USER, 2021-2028 (USD MILLION)
FIGURE 40 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY END USER, CAGR (2021-2028)
FIGURE 41 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY END USER, LIFELINE CURVE
FIGURE 42 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 43 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
FIGURE 44 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 45 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 46 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: SNAPSHOT (2020)
FIGURE 47 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY COUNTRY (2020)
FIGURE 48 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY COUNTRY (2021 & 2028)
FIGURE 49 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY COUNTRY (2020 & 2028)
FIGURE 50 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY MODALITY (2021-2028)
FIGURE 51 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENTMARKET: COMPANY SHARE 2020 (%)
FIGURE 52 COMPANY SHARE ANALYSIS
FIGURE 53 COMPANY SHARE ANALYSIS
FIGURE 54 COMPANY SHARE ANALYSIS
FIGURE 55 COMPANY SHARE ANALYSIS
研究方法
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。
DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。
